Research graph
References from Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.neuron.2017.02.022
10.1016/j.neuron.2017.02.022 · 2017 · External reference
10.1016/j.jmb.2019.06.030
10.1016/j.jmb.2019.06.030 · 2019 · External reference
10.1016/j.neuron.2021.02.009
10.1016/j.neuron.2021.02.009 · 2021 · External reference
10.7554/elife.62021
10.7554/elife.62021 · 2020 · External reference
10.7554/elife.71148
10.7554/elife.71148 · 2021 · External reference
10.1038/s41582-024-00955-x
10.1038/s41582-024-00955-x · 2024 · External reference
10.1016/j.celrep.2021.109872
10.1016/j.celrep.2021.109872 · 2021 · External reference
10.7554/elife.72823
10.7554/elife.72823 · 2021 · External reference
10.1016/j.neuron.2022.08.017
10.1016/j.neuron.2022.08.017 · 2022 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1016/j.molcel.2022.03.007
10.1016/j.molcel.2022.03.007 · 2022 · External reference
10.7554/elife.67381
10.7554/elife.67381 · 2021 · External reference
10.1523/jneurosci.2424-23.2024
10.1523/jneurosci.2424-23.2024 · 2024 · External reference
10.1101/2024.11.19.624255
10.1101/2024.11.19.624255 · External reference
10.1021/acs.jmedchem.4c03127
10.1021/acs.jmedchem.4c03127 · 2025 · External reference
10.1101/2025.03.25.644293
10.1101/2025.03.25.644293 · External reference
10.1073/pnas.1918721117
10.1073/pnas.1918721117 · 2020 · External reference
10.1038/nature08833
10.1038/nature08833 · 2010 · External reference
10.1016/j.expneurol.2020.113252
10.1016/j.expneurol.2020.113252 · 2020 · External reference
10.1084/jem.20070868
10.1084/jem.20070868 · 2007 · External reference
10.1016/j.crmeth.2024.100858
10.1016/j.crmeth.2024.100858 · 2024 · External reference
10.1002/cne.22645
10.1002/cne.22645 · 2011 · External reference
